DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTS

被引：181

作者：

KRIPALANI, KJ

MCKINSTRY, DN

SINGHVI, SM

WILLARD, DA

VUKOVICH, RA

MIGDALOF, BH

机构：

[1] SQUIBB INST MED RES,DEPT CLIN PHARMACOL,NEW BRUNSWICK,NJ 08903

[2] MED CTR PRINCETON,CLIN PHARMACOL UNIT,PRINCETON,NJ

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1980年 / 27卷 / 05期

关键词：

D O I：

10.1038/clpt.1980.90

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：636 / 641

页数：6

共 10 条

[1] IMPROVED SCINTILLATION COCKTAIL OF HIGH-SOLUBILIZING POWER [J].

ANDERSON, LE ;

MCCLURE, WO .

ANALYTICAL BIOCHEMISTRY, 1973, 51 (01) :173-179

[2] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

[3] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

KERSHAW, GR ;

TURINI, GA ;

VUKOVICH, RA ;

MCKINSTRY, DN ;

GAVRAS, I .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :19-23

[4] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].

CASE, DB ;

ATLAS, SA ;

LARAGH, JH ;

SEALEY, JE ;

SULLIVAN, PA ;

MCKINSTRY, DN .

PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206

[5]

FERGUSON RK, 1977, LANCET, V1, P775

[6] ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].

GAVRAS, H ;

BRUNNER, HR ;

TURINI, GA ;

KERSHAW, GR ;

TIFFT, CP ;

CUTTELOD, S ;

GAVRAS, I ;

VUKOVICH, RA ;

MCKINSTRY, DN .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995

[7] DESIGN OF SPECIFIC INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - NEW CLASS OF ORALLY ACTIVE ANTIHYPERTENSIVE AGENTS [J].

ONDETTI, MA ;

CUSHMAN, DW .

SCIENCE, 1977, 196 (4288) :441-444

[8]

RUBIN B, 1978, J PHARMACOL EXP THER, V204, P271

[9]

WONG KK, 1978, PHARMACOLOGIST, V20, P213

[10]

WONG KK, 1979, PHARMACOLOGIST, V21, P155

← 1 →